Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Xtalks Vitals News

Pharmaceutical Biotech Medical Device Food Clinical Trials Drug Safety Pharmaceutical Marketing Life Science

Kite Pharma Secures FDA Approval for CAR-T Immunotherapy

October 20, 2017

Kite Pharma’s Yescarta (axicabtagene ciloleucel) has become the second CAR-T immunotherapy to be approved in the US, with an indication in treating adult patients with relapsed or refractory large B-cell lymphoma.

Featured In: Biotech News

THE LATEST
Fallopian Tubes Found to be Site of Origin for Most Ovarian Cancers

October 20, 2017 - This year, over 22,000 women will be diagnosed with ovarian cancer but a new study conducted by researchers at Perlmutter Cancer Center at NYU Langone Health suggests that most of these malignancies begin in another part of the reproductive system: the fallopian tubes.

Featured In: Life Science News


Food Companies are Looking for the Next Sriracha

October 19, 2017 - The Sriracha trend might be coming to an end and companies are looking for the next big hot sauce star to feature in their line-up.

Featured In: Food News

WATCH & PARTICIPATE IN THESE WEBINARS 


Evolving Best Practices for Working with Authors of Scientific Publications – Authorship and Beyond

Clinical Event Adjudication: Comprehensive and Efficient Dossier Review Using a Global On-Line Solution


CFIA Recalling Mechanically Tenderized Steaks in Canada for E. coli

October 19, 2017 - The Canadian Food Inspection Agency posted a recall for mechanically tenderized steaks at the request of Vantage Foods Inc. on Tuesday.

Featured In: Food News


Study: Gender May Be Important When Matching Blood Transfusion Recipients to Donors

October 19, 2017 - According to a new study published in JAMA, gender and a history of pregnancy among female donors may have an impact on how well blood donors and recipients can be matched.

Featured In: Life Science News


New Ingredients Can Reduce The Amount Of Sugar In Products But Still Maintain Sweetness

October 18, 2017 - Ingredion and Kerry introduce new ingredients that will lower the amount of sugar on Nutrition Facts labels, while still maintaining the sweetness of products.

Featured In: Food News


Whole Foods’ CEO Says “Marriage” to Amazon Has Been Challenging

October 18, 2017 - Whole Foods CEO John Mackey said the “marriage” to Amazon has been challenging for the company in a keynote speech.

Featured In: Food News


Allergan’s Restasis Will Soon be Open to Generic Copycats After Ruling in Patent Case

October 18, 2017 - Four patents for Allergan’s blockbuster dry eye drug Restasis were invalidated by a federal judge on Monday, potentially leaving the drug open to generic copies.

Featured In: Pharmaceutical News


Is an Expanded Indication Coming for Excelixis’ Cancer Drug?

October 18, 2017 - San Francisco-based biotech Excelixis has posted positive results for its cancer drug cabozantinib, which may support an expanded indication for the drug in the treatment of advanced hepatocellular carcinoma (HCC).

Featured In: Clinical Trials News


Janssen’s iSTEP Mobile Clinical Trials Program Aims to Improve Medication Adherence

October 17, 2017 - Johnson & Johnson’s pharmaceutical division Janssen has developed a new mobile clinical trials platform to streamline clinical supply management and potentially improve patient reporting and medication adherence in these studies.

Featured In: Clinical Trials News


Antihypertensive Drugs Don’t Fully Restore Microvascular Function

October 17, 2017 - According to Researchers at Lancaster University, standard treatments for high blood pressure may not be addressing damaging circulation issues in small blood vessels.

Featured In: Pharmaceutical News


Fluorescent Dye Helps Surgeons See Cancerous Lymph Nodes

October 16, 2017 - To help identify cancerous lymph nodes, surgeons at Penn Medicine are leading a trial to see whether a fluorescent dye can be a better way to identify diseased tissue during surgery.

Featured In: Life Science News


Pharma Paradox: The More Side Effects Listed in a Drug Ad, The Safer It’s Perceived to Be

October 13, 2017 - Researchers at London Business School have found that pharma advertisements containing a longer “laundry list” of potential side effects were rated as less risky, compared to those that share just a few, more serious reactions.

Featured In: Pharmaceutical Marketing News


New California Law Aims to Increase Transparency in Drug Pricing

October 11, 2017 - Under the new law, pharmaceutical and biotech companies will be required to give 60-days notice before increasing the price of a drug more than 16 percent over two years.

Featured In: Biotech News, Pharmaceutical News


CRISPR Helps Researchers Design More Representative Preclinical Cancer Models

October 10, 2017 - New research published in the journal Cell Stem Cell suggests that multiplex CRISPR-Cas9 could be used to generate mouse models of disease which could be a more accurate predictor of the human response to a drug.

Featured In: Biotech News


Allergan Gains Another Approval for Botox Amid Patent Controversy Over Restasis

October 5, 2017 - Pharmaceutical company Allergan has just received another FDA approval for its blockbuster cosmetic product Botox.

Featured In: Pharmaceutical News


Using Next-Gen Sequencing to Detect Asymptomatic Pancreatic Cancer

October 4, 2017 - Researchers at the University of Pittsburgh Medical Center (UPMC) have developed a genetic test that can help identify pancreatic cancer, even when a patient experiences no obvious symptoms of disease.

Featured In: Life Science News


Dosing Blood Thinner Drug Based on Genetic Testing Results Could Improve Patient Safety

October 3, 2017 - Research published in the Journal of the American Medical Association has found that using genetic testing results to guide dosing decisions could help mitigate the risk of warfarin-associated side effects.

Featured In: Drug Safety News


Medical Device Manufacturers More Likely to Issue Recall After Subsequent Visits from Same FDA Inspector

October 2, 2017 - According to a new study published in the journal Manufacturing & Service Operations Management, US-based medical device manufacturers could decrease their annual product recalls by as much as 20 percent if they were visited by different FDA representatives for each inspection.

Featured In: Medical Device News


Abbott’s Continuous Glucose Monitoring System to Replace Finger Sticks for Diabetics

September 29, 2017 - American patients with diabetes may never again have to use a finger stick to monitor their blood glucose levels thanks to Abbott’s new FreeStyle Libre Flash Glucose Monitoring System.

Featured In: Medical Device News


Aftermath of Brexit Could Cripple EMA

September 28, 2017 - A recent survey conducted by the European Medicines Agency (EMA) has found that as little as six percent of its staff would be willing to relocate once the regulatory body moves its headquarters out of London, England.

Featured In: Pharmaceutical News


Axovant’s Alzheimer’s Drug Fails in Phase III Clinical Trial

September 27, 2017 - Swiss pharmaceutical company Axovant Sciences announced yesterday that their investigational Alzheimer’s disease drug intepirdine failed to meet its co-primary endpoints in a Phase III clinical trial.

Featured In: Clinical Trials News


FDA Targets Over 500 Online Pharmacies to Curb Distribution of Counterfeit Drugs

September 26, 2017 - The US Food and Drug Administration (FDA) recently targeted 500 websites that sold medications, such as opioids and injectables, to patients in the US.

Featured In: Drug Safety News


25 Percent of Cancer Patients Use Cannabis to Manage Pain and Stress

September 25, 2017 - Nearly one quarter of cancer patients treated at the Seattle Cancer Center Alliance reported that they currently use cannabis to manage the physical and psychological symptoms of treatment, according to researchers at Fred Hutchinson Cancer Research Center.

Featured In: Life Science News


Will Trump Demand Lower Price for Opioid Overdose Drug?

September 22, 2017 - Despite its status as a generic, the manufacturers of naloxone have increased the price of the medication in recent years, prompting 50 congressional members to encourage President Donald Trump to push drugmakers to lower the drug’s cost.

Featured In: Drug Safety News


Researchers Identify Role of ApoE4 Gene as Possible Drug Target in Alzheimer’s Disease

September 21, 2017 - A team of neurology researchers at Washington University School of Medicine in St. Louis have found that in the presence of the ApoE4 protein, another protein known as tau forms tangles in the brain which contributes to neuronal damage characteristic of Alzheimer’s disease.

Featured In: Life Science News


New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths

September 20, 2017 - Clinicians at The University of Texas MD Anderson Cancer Center have published new guidelines in the journal, Nature Reviews Clinical Oncology, which could help in the management of these toxicities.

Featured In: Biotech News, Drug Safety News


Microneedle Skin Patch Could Treat Common Metabolic Disorders

September 19, 2017 - Researchers at Columbia University Medical Center (CUMC) and the University of North Carolina have developed a microneedle skin patch impregnated with a drug capable of converting white fat into calorie-burning brown fat.

Featured In: Medical Device News


Allergan’s Canadian Uterine Fibroid Registry Yields Better Understanding of Condition

September 19, 2017 - A patent registry launched by Allergan with the aim of collecting observational data from Canadian women diagnosed with uterine fibroids is reportedly the first of its kind to compile this kind of real-world data.

Featured In: Clinical Trial News


Avastin Biosimilar Becomes First FDA-Approved Copy-Cat for Cancer

September 18, 2017 - In an historic event, the US Food and Drug Administration (FDA) has approved a biosimilar version of Roche’s cancer treatment Avastin (bevacizumab).

Featured In: Biotech News


Will an Open-Access Clinical Trials Database Improve Drug Development?

September 18, 2017 - New Jersey-based business intelligence firm OZMOSI has launched a free-to-use, open-access database of clinical trial data collected from studies around the world.

Featured In: Clinical Trial News


First Oral Drug for Type 1 Diabetes Could be Available in 2018

September 15, 2017 - A type 1 diabetes drug being codeveloped by Lexicon Pharmaceuticals and Sanofi could be the first oral treatment approved for the autoimmune disease following the release of promising Phase III clinical trial results.

Featured In: Clinical Trial News


New Antibiotic Paired with Leukemia Treatment Lowers Infection Risk in Pediatric Patients

September 15, 2017 - Researchers at St. Jude Children’s Research Hospital have found an antibiotic that could help prevent patients from contracting these infections, without contributing to antibiotic resistance.

Featured In: Clinical Trial News


95 Percent of Americans Take Preventive Measures to Avoid Cancer, According to Mayo Clinic Survey

September 14, 2017 - With some statistics predicting that one in two individuals will be diagnosed with cancer at some point in their lives, people are increasingly taking their health into their own hands in an attempt to reduce their risk.

Featured In: Life Science News


Hurricane Irma’s Floodwaters Contain Pathogens That Cannot Be Washed Off Produce

September 14, 2017 - When the extremely dangerous category five storm, Hurricane Irma, crashed into Florida on Sunday, it brought along much more than floodwater and violent wind gusts.

Featured In: Food News


Onxeo Partners with Monopar Therapeutics on Development of Severe Oral Mucositis Drug

September 14, 2017 - After getting Validive (clonidine mucoadhesive buccal tablet), a drug designed to treat a common side effect of cancer treatment, through a Phase II clinical trial, Danish drugmaker Onxeo sought out a development partner for their candidate.

Featured In: Clinical Trials News


Teva Names New CEO

September 13, 2017 - Israel-based pharmaceutical company Teva has announced that Kåre Schultz will replace Dr. Yitzhak Peterburg as President and CEO of the multinational.

Featured In: Pharmaceutical News


Leica’s Fluorescence Microscope Filter Helps Surgeons See Blood Flow in the Brain

September 13, 2017 - The US Food and Drug Administration (FDA) has approved Leica Microsystems’ FL560 fluorescence microscope filter to help surgeons better visualize cerebrovascular blood flow during neurosurgical procedures.

Featured In: Medical Device News


Johnson & Johnson Stops Hepatitis C Drug Development Program

September 12, 2017 - In the wake of Gilead’s string of hepatitis C therapy approvals, Johnson & Johnson’s pharmaceutical division, Janssen, has announced that it will cease development for the infectious disease.

Featured In: Pharmaceutical News


3,500 Job Cuts at Eli Lilly Signal Change in Focus

September 12, 2017 - Pharmaceutical company Eli Lilly has announced it will be implementing around 3,500 layoffs globally, in an effort to “streamline operations.”

Featured In: Pharmaceutical News


Load More News


AstraZeneca Posts Favourable Results for First-in-Class Asthma Drug

September 11, 2017 - Results from AstraZeneca’s Phase IIb PATHWAY clinical trial suggest that the antibody drug tezepelumab could offer a new treatment option for patients with severe, uncontrolled asthma.

Featured In: Clinical Trial News


Cancer-Detecting Pen to Help Guide Surgeons in Tumor Resection

September 11, 2017 - Researchers at The University of Texas at Austin have developed a disposable cancer identification pen capable of rapidly identifying malignant tissue during surgery.

Featured In: Medical Device News


Earth Fare Introduces New Low-Price ‘Clean Food Security’ Meals

September 8, 2017 - Earth Fare unveils a new “Clean Food Security” program that can feed a family of four for under ten dollars per meal.

Featured In: Food News


Johnson & Johnson Launches Neurovascular Business with Focus on Developing Stroke Therapies

September 8, 2017 - The medical devices unit of American multinational Johnson & Johnson has announced the formation of a new neurovascular business, Cerenovus.

Featured In: Medical Device News


Low-Dose Chemotherapy Could be Just as Effective as Higher Doses for Treating Liver Cancer

September 8, 2017 - Treating patients with hepatocellular carcinoma using a lower dose of the chemotherapy drug sorafenib appears to have no negative impact on patient survival time, according to a new study published in the Journal of Clinical Oncology.

Featured In: Drug Safety News


Expanded Prenatal Genetic Screening Could Help Identify Chromosomal Abnormalities

September 7, 2017 - Miscarriage and other abnormalities during pregnancy are often left unexplained, but a group of researchers now say that extending our prenatal screening efforts to include the sequences of all 24 human chromosomes could help to detect these issues.

Featured In: Life Science News


Novartis to See Change in Leadership in 2018

September 6, 2017 - Just one week after being the first biopharmaceutical company to be granted the US Food and Drug Administration (FDA) approval for a CAR-T immunotherapy, Novartis CEO Joseph Jimenez has announced he will be giving up his position in 2018.

Featured In: Pharmaceutical News


Hemodialysis Device Approved for Home Use Could Improve Quality of Life for Kidney Failure Patients

September 5, 2017 - The US Food and Drug Administration (FDA) has approved NxStage Medical’s System One for solo home hemodialysis, alleviating renal patients’ reliance on nurses and other care providers.

Featured In: Medical Device News


First CAR-T Cell Immunotherapy Approved in US Signals Paradigm Shift in Cancer Treatment

September 1, 2017 - Novartis’ Kymriah (tisagenlecleucel) is indicated for the treatment of pediatric and young adult patients with refractory or relapsed acute lymphoblastic leukemia (ALL).

Featured In: Biotech News


Hormel Issues Price Increase for Meat Products Amid Increasing Demand for Bacon

September 1, 2017 - The current demand for bacon is so high that farmers cannot raise pigs fast enough to meet it.

Featured In: Food News


FDA Approves New Antibacterial for UTIs

August 31, 2017 - Rempex Pharmaceuticals’ antibacterial drug, Vabomere, has been approved by the US Food and Drug Administration (FDA) to treat adults with complicated urinary tract infections (cUTI).

Featured In: Pharmaceutical News


FDA First: Adamas Parkinson’s Drug Approved for Dyskinesia

August 30, 2017 - The US Food and Drug Administration (FDA) has approved the first therapy for patients with Parkinson’s disease-associated dyskinesia.

Featured In: Pharmaceutical News


Gilead to Acquire Kite Pharma for $11.9 Billion in Immunotherapy Deal

August 29, 2017 - Biopharmaceutical company Gilead Sciences announced on Monday that it would be buying cancer immunotherapy business Kite Pharma in a deal worth $11.9 billion.

Featured In: Biotech News


Could a Blood Test Reduce the Need for Colonoscopies in the Diagnosis of Ulcerative Colitis?

August 29, 2017 - Researchers at the Institute for Biomedical Sciences at Georgia State University have developed a blood test which uses infrared spectroscopy to screen patients for this type of inflammatory bowel disease (IBD).

Featured In: Medical Device News


Cardiome Resubmission of Atrial Fibrillation Drug Application to FDA Uncertain

August 25, 2017 - The regulator refused to approve Brinavess (vernakalant hydrochloride, IV) and advised the drugmaker that their compiled data would be insufficient for a resubmission.

Featured In: Pharmaceutical News


Chemotherapy Resistance Linked to BRCA Gene in Breast and Ovarian Cancers

August 24, 2017 - Researchers at the Perelman School of Medicine at the University of Pennsylvania have identified a relationship between the genetic status of tumors and risk of resistance to chemotherapy in patients with a confirmed BRCA1/2 mutation.

Featured In: Life Science News


FDA User Fee Act Reauthorization Signed into Law by President Trump

August 23, 2017 - The Food and Drug Administration (FDA) Reauthorization Act (FDARA) of 2017 was officially signed into law on Friday by President Donald Trump.

Featured In: Pharmaceutical News


Dr. Reddy’s Laboratories Launches New Ad Campaign for OTC Pain Reliever

August 23, 2017 - Indian pharmaceutical company Dr. Reddy’s Laboratories is attempting to resurrect over-the-counter (OTC) pain reliever Doan’s, through a new marketing campaign.

Featured In: Pharmaceutical Marketing News


Samsung Bioepis and Takeda to Co-Develop Novel Biologic Drugs

August 22, 2017 - Biosimilars drugmaker Samsung Bioepis has joined forces with Takeda Pharmaceutical to develop biologic therapies in novel disease areas.

Featured In: Biotech News


Improving Administration of Blood Thinner Drugs through an Online Course for Nurses

August 22, 2017 - Patients’ refusal of blood thinners can influence a nurse’s decision to administer the drugs, but an online educational program could help to address this issue.

Featured In: Life Science News


Exploring the FDA’s Accelerated Approval Pathway

August 21, 2017 - Investigational new drugs that could fill an unmet medical need are sometimes granted “Accelerated Approval” by the US Food and Drug Administration (FDA) in an effort to make these medicines available to the patients who need them.

Featured In: Pharmaceutical News


Clinical Trial Shows Amgen’s Repatha Does Not Impair Cognition

August 21, 2017 - Amgen’s PCSK9 inhibitor drug Repatha (evolocumab) does not have an effect on cognitive function, according to the results from a recent Phase III clinical trial.

Featured In: Clinical Trials News


Patients with Parkinson’s Disease May Benefit from Telemedicine-Based Care

August 18, 2017 - A new study published in the journal, Neurology, suggests that taking a telemedicine approach to Parkinson’s care could be just as effective for patients as visits to their local doctor’s office.

Featured In: Life Science News


One Third of Cancer Patients Report Their Out-of-Pocket Treatment Costs are Higher Than Expected

August 18, 2017 - While insurance coverage can help make the cost of cancer treatment more manageable, a new study suggests that it may not do enough to offset the expense.

Featured In: Life Science News


Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News

Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


Activated Charcoal May Prevent Negative Effects of Antibiotics on Microbiome

August 16, 2017 - Researchers at a French biotech company, Da Volterra, believe that a modified version of activated charcoal could solve this problem by allowing antibiotics to kill pathogenic microbes while sparing those that are important to gut health.

Featured In: Life Science News


Kellogg Joins the Probiotic Trend with Special K Nourish Cereal

August 15, 2017 - In an effort to appeal to the changing health food market, the Pop-Tarts maker plans on increasing the fibre content in its packaged goods and later this year, is launching a Special K Nourish cereal with probiotics — bacterial cultures that promote digestive health.

Featured In: Food News


Could Importing Prescription Drugs from Canada Solve the US Drug Pricing Issue?

August 15, 2017 - Senator Bernie Sanders introduced the Affordable and Safe Prescription Drug Importation Act in late February in an effort to provide US-based pharmacies with a legal route of importing less expensive branded pharmaceuticals from Canada.

Featured In: Pharmaceutical News


Cancer Blood Test Detects Mutations to Track Cancer Metastasis

August 15, 2017 - A new highly sensitive blood test – developed by researchers at Stanford University – uses single colour digital PRC to characterize genetic mutations in circulating cancer cells.

Featured In: Life Science News


President Trump Declares a National Emergency over Opioid Crisis

August 14, 2017 - The opioid crisis will officially be declared a “national emergency” in the US by President Donald Trump.

Featured In: Drug Safety News


Cholera Vaccines May Not Fully Protect Children against Deadly Diarrheal Disease

August 14, 2017 - While adults immunized against cholera may be well-protected, children who receive the same vaccines may be not be, according to a review conducted by researchers at Johns Hopkins Bloomberg School of Public Health.

Featured In: Life Science News


Using Fluorescence to Detect Cellular Stress and Improve Drug Safety

August 11, 2017 - Using a fluorescent sensor designed to be activated by misfolded proteins inside the cell, researchers at Penn State University have developed a novel method to test the safety of new drugs.

Featured In: Drug Safety News


Type 1 Diabetes Could Eventually Be Treated Using Immunotherapy

August 11, 2017 - Researchers at the Cardiff University School of Medicine have found that an immunotherapy designed to treat diabetes was both safe and effective when tested in a small clinical trial.

Featured In: Clinical Trials News, Biotech News


Can Medicinal Cannabis Reduce Opioid Use for Chronic Pain?

August 10, 2017 - A research team has been granted $3.8 million in funding from the National Institutes of Health (NIH) to conduct the first long-term study of medicinal cannabis versus opioid use among patients with, and without, HIV.

Featured In: Drug Safety News


Handheld Medical Device to Help in Detection of Heart Murmurs

August 10, 2017 - To support the detection of both innocent and pathological heart murmurs, AUM Cardiovascular has developed a non-invasive medical device which uses both acoustic and electrocardiogram (ECG) technology.

Featured In: Medical Device News


Study Finds Common Chemotherapy Could Contribute to Cancer Metastasis

August 9, 2017 - Chemotherapy drugs are often a key component of cancer treatment, however a new study has found a common chemotherapeutic agent, paclitaxel, could activate a pro-metastasis gene.

Featured In: Drug Safety News


Medication Adherence Startup Raises $1.6 Million in Funding

August 9, 2017 - Using predictive analytics and individualized patient engagement strategies, digital health startup Groove Health hopes to improve medication adherence.

Featured In: Life Science News


Researchers Use CRISPR to Repair Inherited Mutation Which Causes Cardiac Condition

August 8, 2017 - Using CRISPR gene editing, researchers at Oregon Health & Science University have successfully repaired a heart disease-causing mutation that can contribute to heart failure and sudden cardiac death.

Featured In: Biotech News


AbbVie’s 8-Week Hepatitis C Drug to Rival Gilead’s Bestselling Therapies

August 8, 2017 - The US Food and Drug Administration (FDA) has just approved AbbVie’s Mavyret (glecaprevir/pibrentasvir), the first treatment for hepatitis C to show a 98 percent cure rate in as little as eight weeks.

Featured In: Pharmaceutical News


FDA Approves Celgene’s AML Treatment Paired with Abbott’s Companion Diagnostic

August 4, 2017 - Patients with acute myeloid leukemia (AML), an aggressive form of blood cancer, could now have a new treatment option thanks to the US Food and Drug Administration’s (FDA) approval of Celgene’s Idhifa (enasidenib).

Featured In: Biotech News, Medical Device News


Johnson & Johnson Debuts New DTC Crohn’s Disease Ad for Stelara

August 3, 2017 - J&J subsidiary Janssen, has released a new direct-to-consumer (DTC) ad promoting Stelara’s latest indication in the treatment of Crohn’s disease.

Featured In: Biotech News, Pharmaceutical Marketing News


FDA Approves Heart Health Claim for Soybean Oil

August 2, 2017 - The US Food and Drug Administration (FDA) will now allow food manufacturers to include a heart health claim on products containing soybean oil.

Featured In: Food News


Study Finds Zika Virus is Unlikely to be Transmitted through Saliva

August 2, 2017 - The primary mode of transmission for the Zika virus is thought to be through the blood, however worries that the virus could be passed along through other bodily fluids prompted researchers at the University of Wisconsin-Madison to study saliva’s virus-harboring potential.

Featured In: Life Science News


Depression Combined with Heart Disease Leads to Increased Death Risk

August 1, 2017 - According to researchers at Intermountain Healthcare in Salt Lake City, patients with coronary heart disease who later develop depression could be twice as likely to die, compared to non-depressed patients.

Featured In: Life Science News


FDA-Approved Fentanyl Drug Screening Assay to Help Identify Opioid Abuse

August 1, 2017 - For the first time, the US Food and Drug Administration (FDA) has approved a urine-based immunoassay to detect fentanyl in living patients.

Featured In: Drug Safety News, Medical Device News


Health Law Researchers Highlight Consent Problems with Biobank Sample Collection

July 31, 2017 - While biobank activity has intensified over the last several decades, a recent essay published in PLOS Biology suggests that the ethical and legal issues surrounding patient consent for sample and health information collection has yet to be standardized.

Featured In: Life Science News


Patient Anonymity in Clinical Trials Supported by Two De-Identification Methods

July 31, 2017 - A recent study – published Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research – looked at two de-identification methods for clinical trials data, known as k-anonymization and adding a “fuzzy factor.”

Featured In: Clinical Trials News


760 New Genetic Drug Targets Identified by Cancer Researchers

July 28, 2017 - A new cancer dependency map, developed by researchers at the Broad Institute of MIT and Harvard, and the Dana-Farber Cancer Institute, has identified over 760 genes which could be potential drug targets for future anti-cancer therapies.

Featured In: Pharmaceutical News


Approved Alzheimer’s Drug Could Reduce Inflammation in Patients with Metabolic Syndrome

July 28, 2017 - A recent report published in the journal JCI Insight suggests that an existing Alzheimer’s drug could also be used to treat patients with metabolic syndrome, a condition characterized by high blood pressure, elevated glucose levels, high cholesterol and excess fat around the midline.

Featured In: Clinical Trials News, Pharmaceutical News


Hydrogel Drug Delivery Could Improve Safety of Slow-Release Medications

July 27, 2017 - The hydrogel remains intact when exposed to the harsh conditions in the gastrointestinal tract, and can be triggered to release its drug payload using an external signal.

Featured In: Pharmaceutical News


Doctors Should Stop Telling Patients to Complete their Course of Antibiotics, Infectious Disease Specialists Say

July 27, 2017 - While it’s been believed that early discontinuation of antibiotics could help drive antibiotic resistance among pathogens, a new paper published in the BMJ suggests that this idea is outdated.

Featured In: Life Science News, Drug Safety News


Positive Clinical Trial Results Prompt Genocea to Push Herpes Drug into Phase III

July 26, 2017 - The data from Genocea Biosciences’ Phase IIb clinical trial for the company’s herpes drug candidate have just been released, and it looks like the biopharmaceutical firm will be pushing the immunotherapy into Phase III.

Featured In: Clinical Trials News


Study: Chemotherapy Before Surgery Improves Survival in Breast Cancer Patients

July 26, 2017 - An observational study conducted by Italian researchers has found that breast cancer patients treated with chemotherapy before undergoing surgery to remove the tumor had a better rate of short- and long-term survival.

Featured In: Life Science News


Long-Acting Antiretroviral Therapy to Reduce Pill Burden on HIV Patients

July 25, 2017 - Researchers from the University of North Carolina have shown that a monthly ART injection could be as effective – or even more effective – compared to standard ART at preventing HIV from once again becoming infectious.

Featured In: Biotech News


New Self-Injectable Form of Lupus Drug Approved by the FDA

July 25, 2017 - Patients with systemic lupus erythematosus (SLE) will now have the option to self-inject their medication thanks to the FDA approval of GSK’s reformulated lupus drug, Benlysta (belimumab).

Featured In: Biotech News


Canadian Chicken Farmers to Further Reduce Use of Antibiotics

July 24, 2017 - The Chicken Farmers of Canada, a national group dedicated to supporting poultry farmers and helping them meet consumer demand for chicken, has announced their strategy for eliminating the use of certain antimicrobials in meat production.

Featured In: Food News


Neonatal MRI Medical Device Approved by the FDA

July 24, 2017 - Medical device maker Aspect Imaging has received US Food and Drug Administration (FDA) approval for its Embrace Neonatal MRI System.

Featured In: Medical Device News


PhRMA Industry Group Takes Defensive Stance on Drug Pricing in New Campaign

July 21, 2017 - The pharmaceutical industry trade group PhRMA has launched a campaign called “Let’s Talk About Cost” in which the lobbying group seeks to answer patients’ common questions about drug pricing.

Featured In: Pharmaceutical Marketing News


Gilead’s Newest Hepatitis C Drug Gets FDA Approval

July 21, 2017 - Dominant player in the chronic hepatitis C virus (HCV) market Gilead has received US Food and Drug Administration (FDA) approval for its newest treatment, Vosevi.

Featured In: Pharmaceutical News


Detecting Alzheimer’s Biomarkers in the Blood Could Improve Early Diagnosis

July 20, 2017 - In an effort to improve rates of early diagnosis and intervention, researchers at Washington University in St. Louis have developed a blood test that can detect some of the hallmarks of Alzheimer’s disease.

Featured In: Biotech News


Insurance Coverage Under the Affordable Care Act Supports Clinical Trial Enrollment, Says Study

July 20, 2017 - Since the Patient Protection and Affordable Care Act (ACA) was passed in 2010, insurance approval for patients wishing to participate in oncology clinical trials has increased, according to a recent study published in the journal, Clinical Cancer Research.

Featured In: Clinical Trial News


FDA Approves Puma Biotechnology’s Extended Adjuvant Therapy for Breast

July 19, 2017 - Puma Biotechnology’s breast cancer drug Nerlynx (neratinib) has been approved by the US Food and Drug Administration (FDA).

Featured In: Biotech News


CAR-T Cell Therapy Shows Promise as Leukemia Treatment in Early Stage Clinical Trial

July 19, 2017 - About 70 percent of clinical trial participants with chronic lymphocytic leukemia experienced tumor shrinkage after being treated with CAR-T immunotherapy, according to researchers at Fred Hutchinson Cancer Research Center.

Featured In: Clinical Trial News


Side Effect Risk Could Be Preventing Stroke Patients from Taking Statins

July 17, 2017 - Researchers in the UK have found that stroke survivors may not be taking their statin medicines as prescribed over concerns about potential side effects associated with the drugs.

Featured In: Life Science News, Drug Safety News


Amid Salmonella Scare, Loblaws Recalls President’s Choice Brand Chicken Nuggets

July 17, 2017 - The Canadian Food Inspection Agency (CFIA) has issued a national recall of President's Choice brand Pub Recipe Chicken Nuggets due to possible Salmonella contamination.

Featured In: Food News


Anti-CRISPR Proteins Could Improve Accuracy of Gene Editing

July 14, 2017 - Researchers from the University of California (UC) Berkeley and UC San Francisco have shown that newly-identified anti-CRISPR proteins could help improve the accuracy of the gene editing technique.

Featured In: Biotech News


Eli Lilly Resolves Pending Patent Litigation for Best-Selling Cialis

July 14, 2017 - After going head-to-head with generic drugmakers in the US District Court for the Eastern District of Virginia, Eli Lilly has reached an agreement with the competitors regarding the impending patent expiration of its best-selling erectile dysfunction drug, Cialis (tadalafil).

Featured In: Pharmaceutical News


Allergan Recruits Celebrities to Preventable Blindness Marketing Campaign

July 13, 2017 - Milo Ventimiglia, best known for his portrayal of Jess Mariano in “Gilmore Girls,” has joined actress Alexandra Daddario and football player Victor Cruz to promote Allergan’s See America social media campaign.

Featured In: Pharmaceutical Marketing News


Defymed to Develop an Implantable Device for Insulin Delivery and Improved Diabetes Management

July 13, 2017 - French medical device manufacturer Defymed is developing an insulin delivery device designed to be implanted into the abdomen of patients with type 1 diabetes.

Featured In: Medical Device News


Biomarker Blood Test for Pancreatic Cancer Could Support Early Diagnosis

July 12, 2017 - Researchers at the Perelman School of Medicine at the University of Pennsylvania say they have developed a biomarker panel that could help clinicians detect and diagnose pancreatic cancer.

Featured In: Life Science News


Arena Pharmaceuticals’ Pulmonary Arterial Hypertension Drug Shows Positive Results in Clinical Trial

July 12, 2017 - San Diego-based company Arena Pharmaceuticals has released the results for their Phase II clinical trial of ralinepag, an investigational drug designed to treat pulmonary arterial hypertension (PAH).

Featured In: Clinical Trials News


First New Treatment in Two Decades for Sickle Cell Disease Approved by FDA

July 11, 2017 - Emmaus Life Sciences’ sickle cell disease drug Endari (L-glutamine oral powder) has been approved by the US Food and Drug Administration (FDA).

Featured In: Pharmaceutical News


Campbell’s Soup to Buy Pacific Foods in Deal Worth $700 Million

July 11, 2017 - In an effort to expand its organic offerings, the iconic Campbell Soup Company has entered into an agreement to purchase natural food brand Pacific Foods.

Featured In: Food News


After FDA Order, Endo Removes Opioid Painkiller from Market

July 10, 2017 - Last month, the FDA made a surprising request that Endo Pharmaceuticals remove Opana ER, its opioid pain drug, from the market over concerns surrounding its abuse potential.

Featured In: Drug Safety News


How Reproducible are Preclinical Study Results?

July 10, 2017 - According to McGill University researchers, cancer scientists often believe that preclinical study results can be replicated more often than they actually are.

Featured In: Pharmaceutical News


Parkinson’s Patients Could Have Elevated Risk of Melanoma

July 7, 2017 - According to researchers at the Mayo Clinic, patients diagnosed with Parkinson’s disease could be at an increased risk of developing melanoma.

Featured In: Life Science News


Liquid Biopsies May Offer Valuable Information About Cancer Treatment Response

July 6, 2017 - Non-invasive liquid biopsies could help clinicians determine whether a cancer patient is adequately responding to treatment, and give indications as to why some therapies aren’t working, according to researchers from Massachusetts General Hospital Cancer Center.

Featured In: Life Science News


Sorrento Therapeutics Gets FDA Go-Ahead for Cancer Pain Clinical Trial

July 5, 2017 - The FDA has authorized Sorrento Therapeutics’ Investigational New Drug Application (IND) for their chronic pain drug candidate, Resiniferatoxin (RTX).

Featured In: Clinical Trials News, Biotech News


PPI Problems: Heartburn Drugs Associated with Increased Risk of Death

July 5, 2017 - Millions of patients in the US take proton pump inhibitor (PPI) drugs to keep their heartburn under control, however multiple studies have now linked the medications with an increased risk of developing health problems, including bone fractures, kidney damage and dementia.

Featured In: Drug Safety News


Treating a Rare Complication of Heart Surgery Could Improve Patient Outcomes

June 30, 2017 - Protein-losing enteropathy (PLE) is a condition in which a patient suffers a dramatic loss of proteins into the intestine.

Featured In: Life Science News


CRISPR Add-on Could Make Gene Editing More Accurate

June 29, 2017 - University of Texas (UT) scientists have developed a technique to predict undesirable editing by the CRISPR tool and help researchers design personalized gene therapies on a patient-by-patient basis.

Featured In: Biotech News


Microneedle Patch Could Revolutionize Flu Vaccination

June 28, 2017 - A team of researchers at the Georgia Institute of Technology and Emory University have shown that a microneedle patch may be a safe and effective way of immunizing people against influenza viruses.

Featured In: Medical Device News


FDA Rejects Pfizer's Anemia Drug Biosimilar

June 27, 2017 - Pfizer announced that they have received a Complete Response Letter (CRL) from the FDA regarding its biosimilar version of Amgen’s anemia drug Epogen.

Featured In: Biotech News


Early Alzheimer’s Patients May See Benefit from Anti-Epilepsy Drug

June 27, 2017 - While the processes behind Alzheimer’s disease development aren’t fully understood, recent research has suggested that some cognitive decline could be caused by seizure-like activity in the brains of patients.

Featured In: Clinical Trials News


First Human Colon Organoids Grown in Lab

June 26, 2017 - Using human pluripotent stem cells, researchers at Cincinnati Children's Hospital Medical Center have developed colon-like organoids that can be transplanted into mice.

Featured In: Life Science News


Could Genetic Markers Help Identify Patients at Risk of Opioid Overdose?

June 26, 2017 - Researchers at Erasmus University Medical Center in the Netherlands have identified 10 genes which may help healthcare providers predict which patients could respond poorly to opioid medications.

Featured In: Drug Safety News


Breastfeeding Mothers May Have Lower Risk of Heart Attack and Stroke Later in Life

June 23, 2017 - According to new research published in the Journal of the American Heart Association, women who breastfed their babies could have a lower future risk of suffering a heart attack or stroke.

Featured In: Pharmaceutical News


FDA Approves Shire’s New ADHD Drug

June 23, 2017 - No stranger to the ADHD market, Shire has announced that their new drug Mydayis (mixed salts of a single-entity amphetamine product) had been approved by the FDA.

Featured In: Life Science News


Sarepta Therapeutics to Partner with Genethon on Gene Therapy for Duchenne

June 22, 2017 - Biopharmaceutical company Sarepta Therapeutics and non-profit rare disease R&D company Genethon have decided to partner to develop novel therapies for Duchenne muscular dystrophy (DMD).

Featured In: Biotech News


German Merck Launches Spinoff Immuno-Oncology Company

June 22, 2017 - Merck KGaA has announced the launch of iOnctura SA, a new immuno-oncology company built around two assets from the Healthcare R&D portfolio of the pharmaceutical company.

Featured In: Biotech News


Ikea Promotes Food Products by Offering Fill-in-the-Blanks Recipe Sheets

June 21, 2017 - In an effort to promote the company’s food business, Ikea recently launched a set of recipes printed on parchment paper that encourage consumers to “fill-in-the-blanks” with ingredients, fold the paper and cook the bag in the oven.

Featured In: Food News


Nanomaterial Promotes Bone Growth after Spinal Fusion Surgery

June 21, 2017 - Researchers at Northwestern University have developed a bioactive nanomaterial capable of effectively stimulating bone regeneration after spinal fusion surgery.

Featured In: Life Science News


Adamis Pharmaceuticals’ EpiPen Rival Gains FDA Approval

June 20, 2017 - The FDA has approved Adamis Pharmaceuticals’ epinephrine pre-filled syringe, Symjepi.

Featured In: Medical Device News


UK’s NICE Approves New Crohn’s Disease Therapy

June 20, 2017 - The National Institute for Health and Care Excellence has recommended that Janssen’s Crohn’s disease drug Stelara (ustekinumab) be made available to patients in the UK through the NHS.

Featured In: Biotech News


Amazon to Acquire Whole Foods in $13.7 Billion Deal

June 19, 2017 - Online retail giant Amazon has announced that it has entered into a $13.7 billion deal to acquire Whole Foods Market.

Featured In: Food News


Bristol-Myers Squibb Recalls Mislabeled Anticoagulant Drug

June 19, 2017 - Pharmaceutical company Bristol-Myers Squibb has recalled one lot of 5 mg Eliquis (apixaban) tablets after the batch was identified as being mislabeled.

Featured In: Drug Safety News


Wearable Biosensors Could Detect Biomarkers, Pathogens and Pollutants

June 16, 2017 - Rutgers University engineers are developing lab-on- a-chip biosensors that could be integrated into existing wearable devices.

Featured In: Medical Device News


Teva’s Generic HIV Drug Gains FDA Approval

June 16, 2017 - The FDA has approved Teva Pharmaceutical’s generic version of Gilead’s HIV drug, Truvada.

Featured In: Pharmaceutical News


Merck Halts Enrollment in Keytruda Clinical Trials Following Patient Deaths

June 15, 2017 - Merck has announced that they will not be enrolling any new patients into two Phase III clinical trials involving Keytruda (pembrolizumab) following reports of patient deaths.

Featured In: Clinical Trials News, Drug Safety News


Phase II Fail Prompts Acceleron to Discontinue Development of Renal Cell Carcinoma Drug

June 15, 2017 - Biopharmaceutical company Acceleron has announced their renal cell carcinoma (RCC) drug combo failed to meet its primary endpoint in a Phase II clinical trial, prompting the company to discontinue development of the candidate.

Featured In: Clinical Trials News


Ebb Therapeutics Medical Device Cools Frontal Cortex to Offer Relief from Insomnia

June 14, 2017 - Patients experiencing insomnia may reach for over- the-counter (OTC) or prescription sleep aids to help them fall asleep but physicians at Ebb Therapeutics believe that a drug-free treatment may be a safer way to address sleeping troubles.

Featured In: Medical Device News


What’s the Role of Vitamin A in the Development of Diabetes?

June 14, 2017 - A new study conducted by researchers at the Lund University Diabetes Centre in Sweden has identified a novel link between vitamin A and diabetes.

Featured In: Life Science News


Supreme Court Decision to Support Faster Launch of Biosimilar Drugs

June 13, 2017 - Yesterday, the US Supreme Court overturned an original court’s ruling which prevented Novartis from launching its biosimilar of Amgen’s cancer drug Neupogen, until six months after the pharmaceutical company gained FDA approval.

Featured In: Clinical Trials News


Reassessing Clinical Trials Outcome Measures for Fragile X Syndrome Treatments

June 13, 2017 - A recent review of 22 clinical trials testing new treatments for the genetic disease known as fragile X syndrome (FXS), has found that the use of more reliable outcome measures may be necessary in order to show treatment efficacy.

Featured In: Biotech News


FDA and Endo Pull Opioid Pain Drug from the Market

June 12, 2017 - The FDA has asked Endo Pharmaceuticals to pull its opioid pain medication, Opana ER (oxymorphone hydrochloride), from the market amid concerns that the drug’s benefits do not outweigh the potential risk of abuse.

Featured In: Drug Safety News


FDA’s Failure to Ban Perchlorate in Food Packaging Sparks Backlash

June 12, 2017 - Health and consumer groups are urging the FDA to reconsider their decision not to ban perchlorate, a chemical added to food packaging to reduce static electricity.

Featured In: Food News


AMA to Vote on Requiring Drugmakers to Include Drug Prices in DTC Ads

June 9, 2017 - In its upcoming meeting, the American Medical Association (AMA) is set to vote on a resolution which could lead regulators to require drug prices to be included in direct-to-consumer (DTC) ads.

Featured In: Pharmaceutical Marketing News


Blood Biomarker for Huntington’s Disease Identified for First Time

June 8, 2017 - Researchers at University College London (UCL) have identified a blood biomarker which could predict the onset and progression of Huntington’s disease symptoms in patients.

Featured In: Life Science News


1 in 6 Patients with Atrial Fibrillation May Be Getting Wrong Dose of Blood

June 7, 2017 - New research conducted at the Mayo Clinic has found that one in six Americans on blood thinners to treat irregular heart rate – known as atrial fibrillation – could be taking too much or too little of the medication.

Featured In: Drug Safety News


Four Biomarkers Can Help Identify Viral and Non-Viral Causes of Systemic Inflammation

June 7, 2017 - Four blood biomarkers could help doctors decide whether the source of a patient’s systemic inflammation is viral or non-viral in nature.

Featured In: Life Science News


Clinical Assay Detects Zika Virus in Semen

June 6, 2017 - A clinical assay has been shown to reliably detect the Zika virus in semen samples, according to researchers at the Fertility and Cryogenics Lab in Illinois.

Featured In: Life Science News


Additional Insulin Injection May Reduce Heart Disease Risk in Patients with Type 1 Diabetes

June 6, 2017 - A small clinical trial conducted by researchers at the NIHR Newcastle Clinical Research Facility has found that patients with type 1 diabetes who were given an additional insulin injection three hours after consuming a meal may have a decreased risk of developing cardiovascular disease.

Featured In: Clinical Trials News


Italy Attempts to Control Infectious Disease Outbreaks by Implementing Mandatory

June 5, 2017 - In response to a recent outbreak of measles in Italy which has so far affected 1,500 people, the Italian government has made it illegal for parents to prevent their children from receiving 12 essential vaccines.

Featured In: Life Science News


Blood Biomarker Could Facilitate Brain Cancer Diagnosis Five Years Earlier

June 5, 2017 - Weakened interactions between immune proteins known as cytokines could be a biomarker for early diagnosis of brain cancer, according to researchers at Ohio State.

Featured In: Life Science News


Teva’s Phase III Migraine Clinical Trial Returns Positive Results

June 2, 2017 - Teva Pharmaceuticals’ investigational treatment for migraine prevention, fremanezumab, was able to statistically significantly reduce the number of monthly headache days in patients suffering from chronic migraines.

Featured In: Clinical Trials News


Handheld Medical Device to Improve Access to Cervical Cancer Screening

June 2, 2017 - Researchers at Duke University have developed a slim, handheld medical device that could revolutionize cervical cancer screening by putting the power in the hands of the women themselves.

Featured In: Medical Device News


FDA Rejects Sunovion’s New Drug Application for COPD Medication

June 1, 2017 - Sunovion Pharmaceuticals has announced receipt of a Complete Response Letter (CRL) from the FDA in regards to their New Drug Application (NDA) for SUN-101/eFlow (glycopyrrolate), a drug developed for the maintenance of chronic obstructive pulmonary disease (COPD).

Featured In: Pharmaceutical News


PepsiCo in Talks to Acquire Owner of Vita Coco Coconut Water, Say Sources

June 1, 2017 - Beverage giant PepsiCo is reportedly looking to acquire coconut water brand Vita Coco’s parent company All Market Inc, according to a Reuters report.

Featured In: Food News


Thousands of Off-Target Mutations Plague CRISPR Gene Editing

May 31, 2017 - A recent study, set to be published in the journal Nature Methods, has highlighted this fact by reporting that the technology may introduce hundreds or thousands of so-called off-target mutations into the genome.

Featured In: Biotech News


Self-Clearing Catheter Technology Could Improve Lifespan of Implantable Medical Devices

May 31, 2017 - In an effort to improve the lifespan of these implantable medical devices and avoid repeat surgery, engineers at Purdue University have developed a self-clearing catheter that uses magnetic force to keep the catheter free of obstructions.

Featured In: Medical Device News


Patients Show Improved Medication Adherence to HIV Drugs in Recent Years

May 30, 2017 - A recent study of Medicaid data in the US has found that HIV patients are adhering better to their disease management medications, compared to previous years.

Featured In: Pharmaceutical News


GW Pharmaceuticals’ Cannabis Drug Show Promise in Late-Stage Clinical Trial of Epilepsy

May 30, 2017 - UK-based GW Pharmaceuticals has released positive Phase III clinical trial results for its cannabis-derived drug Epidiolex (cannabidiol) in children with a rare form of epilepsy.

Featured In: Clinical Trials News


Cardiac Safety Study Could Encourage Development of Pediatric Medical Devices

May 29, 2017 - Developing specific medical devices for pediatric patients can be challenging, and larger devices designed for adults are often repurposed for use in this vulnerable population, potentially leading to safety concerns.

Featured In: Medical Device News


Kidneys from Diabetic Donors May be Best Transplant Option for Some Patients

May 29, 2017 - According to researchers at the Perelman School of Medicine at the University of Pennsylvania, certain patients awaiting a kidney transplant may benefit from being given an organ from a donor with diabetes.

Featured In: Life Science News


Protagonist Therapeutics Starts Phase I Clinical Trial for Rare Diseases of Iron Overload

May 26, 2017 - A Phase I clinical trial of Protagonist Therapeutics’ biologic drug PTG-300, has commenced in a cohort of healthy volunteers.

Featured In: Clinical Trials News


Lavazza Acquires Controlling Stake in Canada’s Kicking Horse Coffee

May 26, 2017 - Italian coffee company Lavazza, has secured an 80 percent equity stake in Canadian organic and fair-trade coffee company Kicking Horse Coffee, in a deal worth CAD$215 million.

Featured In: Food News


FDA First: Keytruda Approved for Cancer Treatment Based on Biomarker Alone

May 25, 2017 - For the first time, the FDA has approved a cancer treatment for solid tumors based on the presence of a biomarker, as opposed to specifying a tissue of origin.

Featured In: Biotech News


One Year of Medically Assisted Dying in Canada

May 25, 2017 - In June of 2016, the federal government of Canada passed legislation to legalize medically assisted dying.

Featured In: Life Science News


Expanded Indication for Actemra makes it First FDA-Approved Treatment for Giant Cell Arteritis

May 24, 2017 - Genentech’s arthritis drug, Actemra (tocilizumab), was approved by the FDA on Monday to treat adults with giant cell arteritis (GCA).

Featured In: Biotech News


Nanofluidic Device Could Improve Quality of Biologic Drugs

May 24, 2017 - MIT engineers have developed a nanofluidic device capable of assessing the quality of biologic drugs as they’re being manufactured.

Featured In: Biotech News, Drug Safety News


Bioengineered Heart Valve Regenerates Just Like Human Heart Tissue

May 23, 2017 - Over four million people each year suffer from cardiac valve disease, requiring them to undergo surgery to receive a replacement valve.

Featured In: Life Science News


Human Antibodies from Survivor Protect Against All Species of Ebola Virus

May 23, 2017 - A team of researchers have identified the first human antibodies capable of protecting against all three pathogenic strains of the Ebola virus.

Featured In: Life Science News


Shire Releases Positive Late-Stage Clinical Trial Results for HAE Rare Disease Drug

May 19, 2017 - Dublin-based biotechnology company Shire is gearing up to submit a biologics license application (BLA) to the FDA after releasing positive data from its Phase III clinical trial of lanadelumab.

Featured In: Clinical Trials News, Biotech News


Study Finds Hospital-Acquired Anemia Linked with Poorer Patient Outcomes

May 19, 2017 - New research conducted at UT Southwestern Medical Center has found that one in three patients admitted to hospital develop anemia as a result.

Featured In: Life Science News


Scott Gottlieb Takes the Helm of the FDA

May 18, 2017 - One of the first things on his regulatory agenda is to address drug pricing – a hot topic in the US pharmaceutical industry today.

Featured In: Pharmaceutical News


Opioid Prescriptions for Minor Injuries Contribute to Growing Epidemic

May 18, 2017 - While many assume that patients prescribed large quantities of opioid drugs – such as oxycodone – for chronic pain are at the highest risk of abuse and dependence, new research suggests that small prescriptions for these narcotic painkillers could be just as dangerous.

Featured In: Drug Safety News


Drugs Ratings Online Database for Physicians Launched by Sermo

May 17, 2017 - Physicians’ social media network, Sermo, has launched a new database for prescription drugs featuring ratings, reviews and comments.

Featured In: Pharmaceutical Marketing News


Researchers Urge FDA to Update Guidance for Alzheimer’s Drug Approvals

May 17, 2017 - Alzheimer’s disease drugs are notoriously difficult to develop, as they often show efficacy in early stage clinical trials but fail to meet critical endpoints when it comes to the pivotal Phase III study.

Featured In: Pharmaceutical News


Large Cyber-Attack on UK Hospitals and NHS Disrupts Healthcare Service

May 16, 2017 - A large-scale cyber-attack has hit a number of National Health Service (NIH) run hospitals in the UK, disrupting service and prompting healthcare workers to postpone non-emergency procedures.

Featured In: Life Science News


Chemotherapy after Surgery Reduces Risk of Bladder Cancer Recurrence

May 16, 2017 - A large US study has found that treating bladder cancer patients with a common chemotherapy agent after surgically removing their tumor, can significantly help prevent the cancer from coming back.

Featured In: Clinical Trials News


INC Research and inVentiv Health Merge to Form CRO Worth $7.4 Billion

May 15, 2017 - The all-stock transaction is expected to be completed in the second half of this year.

Featured In: Clinical Trials News


Researchers Highlight Food Safety Issues Surrounding Meal Kits

May 15, 2017 - The team of researchers ordered 169 delivered meal kits, including packages that contained 271 meat products, 235 seafood items, and 39 poultry products.

Featured In: Food News


EpiPen May Retain Potency up to Four Years After Expiration Date

May 12, 2017 - The team of researchers from the University of California in San Diego, published their findings in the journal, Annals of Internal Medicine.

Featured In: Medical Device News


32 Percent of FDA- Approved Drugs Associated with Postmarket Safety Events

May 12, 2017 - This trend was identified by researchers in the Department of Medicine at Brigham and Women's Hospital, who published their findings in JAMA.

Featured In: Drug Safety News


Engineered Bone Tissue Could Improve Success of Bone Marrow Transplants

May 11, 2017 - This engineered tissue could act as an incubator for the transplanted cells, allowing them to grow and divide, and eliminated the need for radiation treatment to kill off the patient’s endogenous cells. Image courtesy of Varghese lab, UC San Diego.

Featured In: Life Science News


Low-Dose Cannabis Could Protect Cognitive Function in Aging Brain

May 10, 2017 - A recent study conducted by researchers in Germany has found that mice treated with low doses of tetrahydrocannabinol (THC) – one of the active ingredients found in cannabis – showed a reversal in age-related cognitive decline.

Featured In: Life Science News


Clinical Trial will Test Statins as Multiple Sclerosis Treatment

May 10, 2017 - The study coordinators plan to recruit over 1,000 patients with MS, and estimate the multi-year clinical trial will cost $7 million.

Featured In: Clinical Trials News


Will PTC’s $35,000 Price Tag for Emflaza be Enough to Appease Drug Pricing Critics?

May 9, 2017 - A generic version of the steroid has been sold in other countries for as little as $1,000 per year – a fact that US DMD patients used to take advantage of by importing the medicine from other nations.

Featured In: Pharmaceutical Marketing News


FDA Approves First New ALS Drug in Two Decades

May 9, 2017 - The intravenous infusion treatment is the first to be approved to treat the rare disease in over 20 years.

Featured In: Pharmaceutical News


Glaucoma Biomarker Could Predict Future Vision Loss

May 8, 2017 - Researchers from the Washington University School of Medicine in St. Louis, have identified a biomarker which has the potential to help physicians monitor disease progression and assess the effectiveness of glaucoma medications.

Featured In: Life Science News


Effectiveness of Cancer Immunotherapy Could Be Improved by Blocking Platelet Production

May 8, 2017 - Researchers have identified a new mechanism by which platelets impair T cell activity.

Featured In: Biotech News


Endometrial Cancer Drug Fails in Late- Stage Clinical Trial

May 5, 2017 - Canadian biopharmaceutical company, Aeterna Zentaris, has announced that their investigational endometrial cancer drug failed to show a statistically significant increase in overall survival, compared to doxorubicin chemotherapy, in a recent late- stage clinical trial.

Featured In: Clinical Trials News


Wireless Source Could Power Medical Devices from Outside the Body

May 5, 2017 - Researchers have developed an ingestible electronic capsule which receives power wirelessly through radio waves transmitted by a source outside the body.

Featured In: Medical Device News


Some Patients Taking Repatha Will Receive Full Refund if They Experience a Cardiac Event

May 4, 2017 - Cardiovascular disease patients covered under Harvard Pilgrim health plans will now be eligible for a full refund if they experience a cardiac event while taking Amgen’s cholesterol-lowering drug, Repatha.

Featured In: Biotech News


Physicians Prescribe Fewer Branded Drugs When Sales Rep Visits are Limited

May 4, 2017 - Researchers at the University of California, Los Angeles (UCLA), and Carnegie Mellon University (CMU), have now found that when pharmaceutical sales visits were restricted, doctors changed the way they prescribed drugs to their patients.

Featured In: Pharmaceutical Marketing News


Cell Model of Parkinson’s Disease Could Speed Drug Development

May 3, 2017 - To help in the development of new treatments for Parkinson’s disease, researchers at the University of Buffalo have developed stem cells that mimic these oscillations in cell culture.

Featured In: Biotech News


Gene Editing Used to Trigger Arthritis Vaccine Production in Living Cells

May 2, 2017 - Researchers at Shriners Hospitals for Children in St. Louis, and the Washington University School of Medicine, have used CRISPR gene editing to engineer stem cells capable of producing an anti-inflammatory arthritis vaccine.

Featured In: Biotech News


Medeor to Start Late-Stage Clinical Trial of Immunotherapy for Transplant Patients

May 1, 2017 - Medeor Therapeutics has just received the FDA go- ahead to start a clinical trial of its cell-based immunotherapy, MDR-101. The personalized therapeutic could replace immune-suppressing drugs in patients who have received an organ transplant.

Featured In: Biotech News, Clinical Trials News


Saturated Fat Does Not Clog Arteries, According to Researchers

April 28, 2017 - The researchers cited a systematic review and meta-analysis of observation studies that found no link between saturated fat consumption, coronary heart disease, and death.

Featured In: Life Science News


Canadian Regulator Recalls Pie Shells Over E. Coli Contaminated Flour

April 28, 2017 - Multiple brands of pie and tart shells are being recalled in Canada after the flour used to manufacture them was linked to 28 cases of illness due to infection with E. coli O121.

Featured In: Food News


FDA Sends Warning Letters to Manufacturers of Fake Cancer Drugs

April 27, 2017 - The FDA is cracking down on the sale of illegal cancer drugs by sending warning letters to 14 US companies selling the unapproved products.

Featured In: Life Science News, Drug Safety News


Womb-Like Device Could Increase Survival of Premature Babies

April 27, 2017 - Researchers at the Children's Hospital of Philadelphia (CHOP) have developed a womb-like device which mimics the environmental conditions found inside the uterus.

Featured In: Life Science News, Medical Device News


Samsung Bioepis Receives First FDA Drug Approval for Remicade Biosimilar

April 26, 2017 - South Korea-based biopharmaceutical company, Samsung Bioepsis, has received its first product approval for the US market.

Featured In: Biotech News


New Medici App Has Big Implications for Future of Doctor-Patient Relationship

April 26, 2017 - A new healthcare messaging app, Medici, promises to connect patients with all of their doctors through a single platform.

Featured In: Life Science News


Postmenopausal Women with High Risk of Fracture May Benefit Most from Hormone Therapy

April 25, 2017 - According to a large study conducted by researchers at the University of Buffalo (UB), women with a genetic risk of fractures could receive the most bone-building benefit from hormone therapy.

Featured In: Life Science News


GSK Malaria Vaccine to be Pilot Tested in Three African Countries

April 25, 2017 - Ghana, Kenya and Malawi will become the first countries to test GlaxoSmithKline’s (GSK) malaria vaccine in 2018.

Featured In: Life Science News


AbbVie Posts Late-Stage Clinical Trial Results for Chronic Hepatitis C Drug

April 24, 2017 - Patients with a traditionally challenging to treat subtype of hepatitis C may soon have a new treatment option for the chronic infection.

Featured In: Clinical Trials News


Study: Few Cardiovascular Benefits of Aspirin Therapy for Patients with Peripheral Vascular Disease

April 24, 2017 - A new study conducted by researchers at the University of Florida has found that aspirin therapy may not provide sufficient cardiovascular benefits for patients with peripheral vascular disease.

Featured In: Clinical Trials News

p


 
Copyright © 2016-2017 Honeycomb Worldwide Inc.